Traditional Chinese medicine preparation for treating benign prostatic hyperplasia

Abstract

The invention belongs to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine preparation for treating benign prostatic hyperplasia. The traditional Chinese medicine preparation is prepared from, by weight, 8-12 parts of red ginseng, 12-17 parts of rhizoma atractylodis macrocephale, 12-17 parts of poria, 8-12 parts of zingiberis rhizoma, 8-12 parts of amomi fructus, 6-10 parts of pinelliae rhizoma, 12-17 parts of lycii fructus, 12-17 parts of herba epimedii, 12-17 parts of psoraleae fructus fried with gentle heat, 12-17 parts of cuscutae semen fried with gentle heat, 6-10 parts of cervi cornu pantotrichum fried with gentle heat, 7-12 parts of glycyrrhizae radix et rhizoma praeparata cum melle and 8-12 parts of semen plantaginis fried with gentle heat. A preparing method the traditional Chinese medicine preparation comprises the steps of weighing the raw materials according to parts by weight, and mixing and grinding the raw materials to obtain medicine powder; adding light salt water to the medicine powder, and mixing the mixture to be even to obtain a mixed material; decocting the mixed material for 20-25 minutes, adding a natural antioxidant into the mixed material, continuing to decoct the mixture for 25-30 minutes, and conducting filtering and sterilizing to obtain the traditional Chinese medicine preparation. The prepared traditional Chinese medicine preparation has the functions of invigorating qi, strengthening the spleen, clearing damp, promoting diuresis, tonifying yang and qi, restoring yang, invigorating pulse-beat,warming middle energizer, dispelling coldness and the like, and has good treatment effects on complications which cause the benign prostatic hyperplasia, semen coldness, asthenozoospermia and the like.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine preparation for treating benign prostatic hyperplasia. Background technique [0002] Hyperplasia of the prostate, often called benign prostatic hyperplasia, is one of the common diseases of middle-aged and elderly men, and its incidence is increasing with the aging of the global population. The essence of benign prostatic hyperplasia is mainly manifested as hyperemia and swelling of the prostate gland, hyperplasia of glandular connective tissue and smooth muscle, forming multiple spherical nodules, and compressing the urethra; clinically, it is manifested as dysuria, frequency, urgency, nocturia, urinary incontinence, etc. Development may lead to urinary retention, bladder stones, urinary tract infection, hydronephrosis, renal failure, etc., accompanied by complications such as impotence, weak sperm, infertility, weak sperm, an...

AI Technical Summary

Problems solved by technology

Drug treatment will cause relatively large toxic and side effects to the human body; surgical treatment and minimally invasive treatment have the problems of high price, poor safety, and great harm to the human body

Therefore, many medical workers at home and abroad have conducted research on Chinese medicines for prostatic hyperplasia, and achieved certain results; but these Chinese medicines are random and have a slow therapeutic effect; The treatment effect of other complications is poor

For example, the patent application number CN201610683845.4 discloses a Chinese medicine composition for treating benign prostatic hyperplasia, including Chinese medicine composition 1 and Chinese medicine composition 2. Composition 1 consists of the following raw materials in parts by weight: 5-15 parts of aconite, 20-30 parts of cinnamon, 20-40 parts of astragalus, 5-15 parts of red ginseng, 10-20 parts of Puhuang, 10-20 parts of Shigepu, 20-30 parts of Poria cocos, 15-25 parts of fried king buliuxing, 10-20 parts of mallow seeds, 10-20 parts of Qumai, 20-30 parts of Liu Jinu, 10-20 parts of Achyranthes bidentata, 10-18 parts of pangolin; Composition 2 consists of the following raw materials in parts by weight: pangolin 100- 150 parts, 30-50 parts of amber, 40-60 parts of Morinda officinalis, 10-30 parts of agarwood; the combination of these medicines can not only invigorate kidney yang, restore bladder qi, but also eliminate blood stasis and disperse stasis, clear away turbidity, and smooth water channels. Drainage, water and dampness self-benefit; the composition has a good curative effect on prostatic hyperplasia, but has poor curative effect on complications such as impotence, infertility, weak sperm, and fine cold